Publications by authors named "Maeva Lion"

Claim this Profile
R
Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experience.
Cristina Smolenschi, Alice Boileve, Pauline Vaflard, Sarah Watson, Isabelle Sourouille, Maeva Lion

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial).
Mario Campone, Thomas Bachelot, Isabelle Treilleux, Barbara Pistilli, Julia Salleron, Maëva Lion

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer.
Maëva Lion, Alexandre Harlé, Julia Salleron, Carole Ramacci, Mario Campone

Oncol Lett· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Method validation according to ISO 15189 and SH GTA 04: application for the extraction of DNA and its quantitative evaluation by a spectrophotometric assay].
Alexandre Harlé, Maëva Lion, Marie Husson, Cindy Dubois, Jean-Louis Merlin

Ann Biol Clin (Paris)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.
Jean-Louis Merlin, Alexandre Harlé, Maëva Lion, Carole Ramacci, Agnès Leroux

Oncol Rep· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical, diagnostic significance and theranostic interest of PIK3CA gene mutations in breast cancer].
Alexandre Harlé, Maëva Lion, Nicolas Lozano, Jean-Louis Merlin

Bull Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.
Alexandre Harlé, Maëva Lion, Nicolas Lozano, Marie Husson, Valentin Harter

Oncol Rep· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis